Dr Ken Gillman
Critical independent evaluations in psycho-pharmacology
MENU
These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, Duloxetine does not have a ‘badge-engineered’ metabolite derivative to extend its patent, unlike Venlafaxine (Effexor, now out of…
Venlafaxine (Effexor, now out of patent) and its ‘badge-engineered’ metabolite off-spring (desvenlafaxine, Pristiq- in patent, which is even weaker than venlafaxine as an NRI) are examples of drugs whose attribution…
Gillman’s Antidepressant algorithmSummaryThis commentary presents my antidepressant treatment algorithm which incorporates concepts from Bayesian reasoning and ‘critical path analysis’; that makes it a ‘multi-lane’ clinical pathway. It emphasises procedures which…
PsychoTropical is a knowledge and education resource started by Dr Gillman about 20 years ago. It is neither connected with, nor influenced by, any financial backing or interest group of any sort. The opinions expressed relate to Dr Gillman’s special knowledge and expertise as a recognised world-expert in MAOIs and serotonin toxicity.
© PsychoTropical 2026. All Rights Reserved